NCT02692755 · Interventional trial
Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer
Overall registry status Completed
Phase 2 · Phase 3
Conditions Hormone Receptor Positive HER-2 Negative Breast Cancer
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory